loading page

Congenital Dyserythropoietic Anemia Type IV with KLF1 E325K Mutation --
  • Gita Massey,
  • Alden Chesney,
  • Yaddanapudi Ravindranath
Gita Massey
Children's Hospital of Richmond at Virginia Commonwealth University

Corresponding Author:[email protected]

Author Profile
Alden Chesney
Virginia Commonwealth University Medical Center
Author Profile
Yaddanapudi Ravindranath
Wayne State University School of Medicine
Author Profile


Congenital Dyserythropoietic Anemia Type IV (CDA-IV) is still an emerging new disease with approximately 10 cases reported over the past three decades. CDA-IV is known to be caused by a specific mutation in exon 3 of KLF1, an erythroid transcription factor KLF1 with substitution of glutamic acid with lysine at residue 325 (KLF1 E325K). Because of the rarity of this disorder the presenting features are incompletely defined; especially the non-erythroid comorbidities. Here we report a new case, a male child, presenting with fetal hydrops and dysmorphic external genitalia.